Sloning Biotechnology GmbH

Sloning Biotechnology is the innovator and technology leader in the emerging gene synthesis market and provides unique and enabling tools for protein engineers.

SlonomicsTM - Next Generation Gene Synthesis Technology

SlonomicsTM is a novel technology platform for high-throughput gene synthesis. Utilizing a library of universal DNA building blocks, this method completely eliminates the need for individually synthesized single-stranded oligos. SlonomicsTM represents the only technology that can manufacture synthetic genes in an industrialized way. The customer benefits are:

  • Freedom of design
  • High reliability through fully standardized raw materials and processes
  • Short processing time
  • Easy Ordering
  • Transparent pricing

SlonoMaxTM - Key Tool for Protein Engineering

Sloning has used its technology platform to develop SlonoMaxTM; a unique product family for protein engineering approaches. SlonoMaxTM libraries are used for the development and improvement of therapeutic proteins or industrially used enzymes. SlonoMaxTM is the first and only technology that fully controls the number of mutants per sequence position and their ratio. They are called the “intelligent libraries”. These unrivaled types of tailor-made libraries open up a new horizon for protein engineers. The main advantages are:

  • No unwanted mutations
  • No missing mutations
  • Definable representation ratio of mutants

 

Sloning BioTechnology GmbH
Zeppelinstrasse 4
82178 Puchheim
Germany

Telephone:
+49 (0)89 80 90 95 0
Fax:
+49 (0)89 80 90 95 50
Email:
info@sloning.com
Website:
www.sloning.com

 

Sloning North America
875-A Island Drive, Suite # 235,
Alameda, CA 94502
USA

Telephone:
+1 510-287-6600
Fax:
+1 510-227-5070
Email:
info@sloning.com
Website:
www.sloning.com